Shots:

• The testing kit qualitatively detects coronavirus RNA targeting for its specific ORF1ab- N and E gene- and completes the detection of 96 samples within 2hrs- by fast automatic nucleic acid extraction instrument and extraction reagents
• The COVID-19 RT-PCR detection kit has received NMPA’s medical device registration certificate and EC’s CE certification
• The automated testing lowers the risk of operator infection- reduce the probability of cross-contamination in the clinical laboratory and improve detection efficiency

Click here to­ read full press release/ article | Ref: PRNewswire | Image: Fosun Pharma

Related News: Fosun Pharma Signs an Agreement with BioNTech to Develop and Commercialize BNT162 for COVID-19